text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "Bone marrow mononuclear cells"
Too many choices? Use the filter option on the left to narrow your product listing.
1-10 of 880 results
41-50 of 1200 results
  • Macrophage Polarization and Phagocytosis Assays
  • Transfection Protocol for Immature mDC (C57BL/6) - 96-well Shuttle™ Device
    Instructions of use for transfection of immature mouse dendritic cells (C57BL/6) with the P4 Primary Cell 96-well Nucleofector™ Kit
  • Transfection Protocol for Immature mDC (BALB/c) - 96-well Shuttle™ Device
    Instructions of use for transfection of immature mouse dendritic cells (BALB/c) with the P4 Primary Cell 96-well Nucleofector™ Kit
  • the next path to cell and gene therapy success…
    Brochure showcasing Lonza products and servies from discovery to commercialization
  • TechSheet - Poietics™ Human Adipose Derived Stem Cells (ADSC)
  • Transfection Protocol for Mature mDC (C57BL/6) - 96-well Shuttle™ Device
    Instructions of use for transfection of mature mouse dendritic cells (C57BL/6) with the P3 Primary Cell 96-well Nucleofector™ Kit
  • Transfection Protocol for Mature mDC (BALB/c) - 96-well Shuttle™ Device
    Instructions of use for transfection of mature mouse dendritic cells (BALB/c) with the P3 Primary Cell 96-well Nucleofector™ Kit
  • Validation of Cytokines for the Chemically Defined Manufacturing of Human CD34 Positive Hematopoietic Precursor Cells
    Lonza Poster
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.